Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database (Q5977801)

From MaRDI portal
Revision as of 02:08, 15 March 2024 by Daniel (talk | contribs) (‎Created claim: MaRDI profile type (P1460): MaRDI publication profile (Q5976449), #quickstatements; #temporary_batch_1710461149452)
scientific article
Language Label Description Also known as
English
Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database
scientific article

    Statements

    72
    0 references
    6
    0 references
    905-908
    0 references
    9 November 2011
    0 references
    0 references
    0 references
    0 references